Articles

Antimicrobial effects of Ferula GummosaBoiss gum against extended-spectrum β-lactamase producing Acinetobacterclinical isolates

Abstract

Background and Objectives: Acinetobacter spp. are important causes of nosocomial infections. They possess various antibiotic resistance mechanisms including extended spectrum beta lactamases (ESBLs). The aim of this study was to determine antibiotic resistance profile of Acinetobacter clinical isolates especially among ESBL-producing strains and to investigate the antimicrobial effects of oleo-gum-resin extract and essential oil of Ferula gummosa Boiss.
Materials and Methods: 120 Acinetobacter strains were isolated from various clinical samples of hospitalized patients in Baqiyatallah hospital, Tehran during 2011-2012. Antibiotic susceptibility test was performed on the isolates using disk diffusion method. To detect and confirm the ESBL-positive isolates, phenotypic and genotypic tests were performed. Three types of F. gummosa oleo-gum-resin extracts and essential oils were prepared and the bioactive components of F. gummosa Boiss extracts were determined by GC-Mass chromatography. F. gummosa antimicrobial activity was evaluated against standard strain of Acinetobacter baumannii (ATCC19606) as well as Acinetobacter clinical isolates using well and disk diffusion methods. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined by broth microdilution method.
Results: 46 isolates were resistant to all tested antibiotics. All clinical isolates were resistant to cefotaxime. 12.94% of the isolates were phenotypically ESBL-producing among which 94.2% carried ESBL genes (blaPER-1, blaOXA-4 and blaCTX-M) detected by PCR. Oleo-gum-resin of F. gummosa had significant antibacterial activity and alcoholic essential oil had higher inhibitory effect on Acinetobacter strains (MIC of 18.75 mg/ml).
Conclusion: Ferula gummosa extract contained components with well-known antimicrobial effects.

 

Dent LL, Marshall DR, Pratap S, Hulette RB. Multi- drug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis 2010; 10: 196.

Misbah S, Hassan H, Yusof MY, Hanifah YA, AbuBa- kar S. Genomic species identification of Acinetobacter of clinical isolates by 16S rDNA sequencing. Singapore Med J 2005; 46: 461-464.

Abbo A, Navon-Venezia S, Hammer-Muntz O, Krich- ali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005; 11:22-29.

Towner KJ (2006). The Genus Acinetobacter. In: The Prokaryotes 6. Ed, M Dworkin, S Falkow, E Rosen- berg, KH Schleifer, E Stackebrandt. Springer, 3rd ed. New York, USA, pp. 746-758.

Hashemizadeh Z, Bazargani A, Emami A, Rahimi MJ. Acinetobacter antibiotic resistance and frequency of ESBL-producing strains in ICU patients of Namazi Hospital (2008-2009). JQUMS 2010; 14: 47-53.

Jin H, Xu XM, Mi ZH, Mou Y, Liu P. Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treat- ment within nosocomial settings. Chin Med J 2009;122: 301-306.

Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010;16: 35-40.

Peymani A, Nahaei MR, Farajnia S, Hasani A, Mir- salehian A, Sohrabi N, et al. High prevalence of metal- lo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis 2011; 64: 69-71.

Andriamanantena TS, Ratsima E, Rakotonirina HC, Randrianirina F, Ramparany L, Carod JF, et al. Dis- semination of multidrug resistant Acinetobacter bau- mannii in various hospitals of Antananarivo Madagas- car. Ann Clin Microbiol Antimicrob 2010; 9: 17.

Dent L, Marshal D, Hulette R, Pratap S. Next-gen se- quencing of multi-drug resistant Acinetobacter bau- mannii to determine antibiotic resistance genotypes. BMC Bioinformatics 2010; 11: 16.

Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, et al. Risk factors for multi-drug resistant Acine- tobacter baumannii bacteremia in patients with coloni- zation in the intensive care unit. BMC Infect Dis 2010;10: 228.

Manchanda V, Sanchaita S, Singh N. Multidrug resis- tant Acinetobacter. J Glob Infect Dis 2010; 2: 291-304.

Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cef- amandole and cefuroxime in clinical isolates of Kleb- siella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-317.

Sayyah M, Mandgary A, Kamalinejad M. Evaluation of the anticonvulsant activity of the seed acetone extract of Ferula gummosa Boiss. against seizures induced by pentylenetetrazole and electroconvulsive shock in mice. J Ethnopharmacol 2002; 82: 105-109.

Kanani MR, Rahiminejad MR, Sonboli A, Mozaffar- ian V, Kazempour Osaloo S, et al. Chemotaxonomic significance of the essential oils of 18 Ferula species (Apiaceae) from Iran. Chem Biodivers 2011; 8: 503-517.

Mandegary A, Sayyah M, Heidari MR. Antinocicep- tive and Anti-Inflammatory activity of the seed and root extracts of Ferula gummosa Boiss in mice and rats. DARU J Pharm Sci 2004; 12: 58-62.

Zarif kar A, Karami Kheyrabad M, Ejtehadi M, Rast- gar K, Ghaljeh M. Evaluation of Antinociceptive ef- fect of galbanum by formalin test in mice. Armaghan Danesh 2007; 12: 19-27.

Fayaz F, Rahmati Roodsari S, Gachkar L, Pourkaveh B, Ghasemian Safaei H. The antimicrobial activity of Ferula gummosa on bacterial strains isolated from pa- tients with gastroenteritis. Arch Clin Infect Dis 2011; 6:161-164.

Sahebkar A, Iranshahi M. Biological activities of es- sential oils from the genus Ferula (Apiaceae). Asian Biomed 2010; 4: 835-847.

Abedi D, Jalali M, Asghari G, Sadeghi N. Composition and antimicrobial activity of oleogumresin of Ferula gumosa Bioss. essential oil using Alamar Blue™. Res Pharm Sci 2008; 3: 41-45.

Mahboubi M, Kazempour N, Mahboubi A. The effica- cy of essential oils as natural preservatives in vegetable oil. J Diet Suppl 2014; 11: 334-346.

Salehi M, Hashemi Karuie SM, Nasrolahi O, Mobini M, Asghar Hedari M. Effect of aqueous and alcohol- ic extracts of roots of Ferula gummosa Boiss. on the growth of Pseudomonas aeruginosa. J Gorgan Uni Med Sci 2014; 15: 18-22.

CLSI. Performance standards for antimicrobial suscep- tibility testing; Twentieth informational supplement CLSI document M100-S20-U.Wayne, PA: Clinical and Laboratory Standards Institute; 2010.

CLSI. Performance standards for antimicrobial disk susceptibility tests; Approved standard- Eleventh edi- tion. CLSI document M02-A11. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.

Tredget EE, Shankowsky HA, Rennie R, Burrell RE, Logsetty S. Pseudomonas infections in the thermally injured patient. Burns 2004; 30: 3-26.

Tiwari P, Kumar B, Kaur M, Kaur G, Kaur H. Phy- tochemical screening and Extraction: A Review. Int Pharm Sci 2011; 1: 98-106.

Ghalem BR, Mohamed B. Antimicrobial activity deter- mination of the gum of Pistacia atlantica Desf. oil. Afr J Microb Res 2010; 4: 2457-2460.

Sinha M, Srinivasa H, Macaden R. Antibiotic resis- tance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 2007; 126: 63-67.

Moussa HH, Abdel Meguid S, El-Hawaary S. Nov- el antimicrobial compounds among naphthalene and methylenedioxyphenyl derivatives. Pharmazie 1981;36: 805-807.

Desai NC, Shihora PN, Rajpara KM, Joshi VV, Vaghani HV, Satodiya HM, et al. Synthesis, charac- terization, and antimicrobial evaluation of novel naph- thalene-based 1,2,4-triazoles. Med Chem Res 2012; 21:2981-2989.

Ates-Alagoz Z, Altanlar N, Buyukbingol E. Synthesis and antimicrobial activity of new tetrahydro-naphtha- lene-thiazolidinedione and thiohydantoine derivatives. J Heterocyclic Chem 2009; 46: 1375-1379.

Choudhary MI, Batool I, Atif M, Hussain S, At- ta-Ur-Rahman. Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products. J Nat Prod 2007; 70: 849-852.

Ghasemi Y, Faridi P, Mehregan I, Mohagheghzadeh A.Ferula gummosa Ffruits: An aromatic antimicrobial agent. Chem Nat Compd 2005; 41: 311-314.

Files
IssueVol 8 No 4 (2016) QRcode
SectionArticles
Keywords
Acinetobacter spp. antibiotic resistance antimicrobial activity ESBLs Ferula gummosa boiss

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Farid Afshar F, Saffarian P, Mahmoodzadeh Hosseini H, Sattarian F, Amin M, Imani Fooladi AA. Antimicrobial effects of Ferula GummosaBoiss gum against extended-spectrum β-lactamase producing Acinetobacterclinical isolates. Iran J Microbiol. 2016;8(4):263-273.